We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Urinary Enzyme Levels Correlate with Prediabetic Plasma Glucose

By LabMedica International staff writers
Posted on 22 Jan 2013
Urinary N-acetyl-β-D-glucosaminidase (NAG) excretion is increased in patients with impaired glucose tolerance (IGT).

During the oral glucose tolerance test (OGTT) the plasma glucose, urine glucose, and insulin levels correlate strongly with urinary N-acetyl-β-d-glucosaminidase (NAG) levels in prediabetic subjects.

Scientists at the Nippon Medical School (Tokyo, Japan) performed OGTTs on 33 men and 47 women, aged 18 to79 years, who were not yet diagnosed with diabetes mellitus (DM), and in whom HbA1c levels were equal to or greater than 6.8%. More...
The study was carried out from December 2005 through August 2010.

Urinary NAG levels were measured spectrophotometrically with sodio- metacresolsulfonphthaleinyl- N-acetyl-β-D-glucosaminide as a substrate (NAG assay kit, Shionogi & Co., Osaka, Japan). Urinary glucose levels and serum creatinine (Cr) levels were measured with enzymatic assays. The serum levels of cystatin C were measured with the N Latex Cystatin C kit (Siemens Healthcare Diagnostics, Inc., Marburg, Germany) and the fully automated particle-enhanced nephelometric immunoassay.

Forty-two subjects had normal glucose tolerance (NGT), 31 had impaired glucose tolerance (IGT), and seven had DM. NAG levels were significantly higher in subjects with DM and in subjects with IGT than in subjects with NGT. Urinary NAG in the DM group was 8.53 ± 4.96 U/g UCr, which was elevated compared to the NGT group, which ranged from 5.40 ± 3.82 U/g UCr. The IGT group's range was 6.60 ± 2.88 U/g UCr, which was also significantly higher than the nondiabetic group. The NAG level was positively correlated with plasma glucose levels at 120 minutes of the OGTT and was associated with the glycemic status of prediabetic patients.

The authors concluded that that the urinary excretion of NAG with other urinary enzymes in the prediabetic state is an appropriate biomarker for screening for prediabetic renal dysfunction. Their results suggest that postprandial hyperglycemia is an independent factor that causes renal tubular damage in prediabetes patients. The study was published on November 9, 2012, in the Journal of Clinical Laboratory Analysis.

Related Links:

Nippon Medical School
Shionogi & Co.
Siemens Healthcare Diagnostics



New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Serological Pipet Controller
PIPETBOY GENIUS
New
Rapid Test Reader
DIA5000
New
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: EvoLiver is the first test to receive FDA Breakthrough Device Designation in five years in the liver cancer surveillance space (Photo courtesy of Mursla Bio)

Patient-Friendly Blood Test to Transform Liver Cancer Surveillance

Hepatocellular carcinoma (HCC), the most common form of primary liver cancer, is the fastest-growing cause of cancer-related deaths. Although clinical guidelines recommend routine surveillance for high-risk... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: CellLENS enables the potential precision therapy strategies against specific immune cell populations in the tissue environment (Photo courtesy of MIT)

New AI System Uncovers Hidden Cell Subtypes to Advance Cancer Immunotherapy

To produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells, both within and across different tumors. These differences significantly... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.